Istiratumab (MM-141) is an experimental monoclonal antibody for the treatment of cancer. It is a bispecific antibody targeting IGF-1R and ErbB3. It is...
2 KB (87 words) - 00:04, 1 June 2023
Sarclisa mab chimeric CD38 Y multiple myeloma Iscalimab mab human CD40 Istiratumab mab human IGF-1 receptor (CD221) advanced solid tumors Itolizumab Alzumab...
135 KB (4,054 words) - 22:35, 2 July 2024
Ganitumab† Glembatumumab vedotin† Intetumumab§ Ipilimumab Iratumumab§ Istiratumab Icrucumab§ Lexatumumab§ Lucatumumab§ Mapatumumab§ Narnatumab§ Necitumumab...
5 KB (368 words) - 23:51, 17 July 2024
Ganitumab† Glembatumumab vedotin† Intetumumab§ Ipilimumab Iratumumab§ Istiratumab Icrucumab§ Lexatumumab§ Lucatumumab§ Mapatumumab§ Narnatumab§ Necitumumab...
3 KB (129 words) - 01:04, 19 July 2023
conjugate MM-121 (seribantumab) – anti-HER3 monoclonal antibody MM-141 (istiratumab) – IGF-1R and HER3 bispecific monoclonal antibody MM-151 – anti-EGFR...
5 KB (382 words) - 18:38, 10 June 2024
Ganitumab† Glembatumumab vedotin† Intetumumab§ Ipilimumab Iratumumab§ Istiratumab Icrucumab§ Lexatumumab§ Lucatumumab§ Mapatumumab§ Narnatumab§ Necitumumab...
4 KB (241 words) - 13:42, 14 July 2024